Gary Dubin
Director/Board Member chez HILLEVAX, INC.
Profil
Gary Dubin is an Independent Director at HilleVax, Inc. He previously worked as the VP & Head-Late Clinical Development at GlaxoSmithKline Vaccines SRL from 2010 to 2015.
He also served as an Assistant Professor at the University of Pennsylvania.
Dr. Dubin holds a doctorate degree from the University of Pennsylvania.
Postes actifs de Gary Dubin
| Sociétés | Poste | Début |
|---|---|---|
| HILLEVAX, INC. | Director/Board Member | 01/03/2022 |
Anciens postes connus de Gary Dubin
| Sociétés | Poste | Fin |
|---|---|---|
Glaxosmithkline Vaccines Srl
 Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Corporate Officer/Principal | 01/01/2015 |
| University of Pennsylvania | Corporate Officer/Principal | - |
Formation de Gary Dubin
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HILLEVAX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Glaxosmithkline Vaccines Srl
Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Health Technology |
